Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cabergoline
- Development stage
- Approved
- Lead developer
- Pfizer
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Cabergoline is a long-acting dopamine receptor agonist and ergot derivative primarily used to treat hyperprolactinemia (high levels of prolactin hormone). It works by stimulating dopamine D2 receptors in the pituitary gland, which inhibits the secretion of prolactin. This reduction in prolactin helps manage conditions such as prolactinomas (pituitary tumors producing excess prolactin), menstrual and fertility problems related to high prolactin levels, and Parkinson's disease as adjunctive therapy. Cabergoline has a longer duration of action compared to older drugs like bromocriptine and is favored for its efficacy and convenient dosing schedule. It may also be used off-label for lactation suppression, uterine fibroids, acromegaly adjunctive treatment (to suppress hyperprolactinemia), and other disorders associated with elevated prolactin. The drug is taken orally in tablet form.[1][2][3][6]
- Brand names
- Dostinex
- Other names
- CabergolinaCabergolinum
02
Targets
DRD2 (Dopamine D2 Receptor)DRD3 (Dopamine receptor D3)HTR2B (5-Hydroxytryptamine Receptor 2B)
Beyond the preview
Go deeper on cabergoline.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cabergoline.